Showing results (171-180 of 827) with videos related to

Sort By:
Pageof 83
The Patient|April 25, 2024
An Overview of Data Collection in Health Preference ResearchSemra Ozdemir, Matthew Quaife, Ateesha F Mohamed, et al.
The Patient|October 13, 2023
Determining Commonalities in the Experiences of Patients with Rare Diseases: A Qualitative Analysis of US Food and Drug Administration Patient Engagement SessionsCatherine Mease, Lewis J Fermaglich, Karen Jackler, et al.
The Patient|March 22, 2026
Recalibration: Exploring the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Self-Concept for Adults with Cystic FibrosisMaggie Harrigan, Melanie Jessup, Kellie Bennett, et al.
The Patient|October 27, 2018
Symptoms and Concerns Among Children and Young People with Life-Limiting and Life-Threatening Conditions: A Systematic Review Highlighting Meaningful Health OutcomesEve Namisango, Katherine Bristowe, Matthew J Allsop, et al.
The Patient|November 1, 2021
A Standard Set of Value-Based Patient-Centered Outcomes and Measures of Overall Health in AdultsJaheeda Gangannagaripalli, Andrea Albagli, Stacie N Myers, et al.
The Patient|December 12, 2022
How Does the Public Evaluate Vaccines for Low-Incidence, Severe-Outcome Diseases? A General-Population Choice ExperimentF Reed Johnson, Angelyn Fairchild, Dale Whittington, et al.
The Patient|June 13, 2026
Patient Preferences and Treatment Decision Drivers in IDH-Mutant Grade 2 Glioma: An International Discrete Choice ExperimentAshley Parham Ghiaseddin, Kismet Hossain-Ibrahim, Antje Wick, et al.
The Patient|January 25, 2021
Process- and Outcome-Based Financial Incentives to Improve Self-Management and Glycemic Control in People with Type 2 Diabetes in Singapore: A Randomized Controlled TrialMarcel Bilger, Mitesh Shah, Ngiap Chuan Tan, et al.
The Patient|July 11, 2026
Co-Creation of the EpiCom Clinical Trial: Bringing the Tuberous Sclerosis Complex Patient Community, Healthcare Professionals, and the Pharmaceutical Industry TogetherLisa Moore-Ramdin, Agnies van Eeghen, Joanne Stevens, et al.
The Patient|June 29, 2026
Experiences of People with Type 2 Diabetes and Healthcare Professionals with Once-Weekly Insulin Efsitora Alfa in QWINT Phase 3 Trials: Qualitative In-Trial InterviewsWilliam H Polonsky, Emma L Low, Carla Dias-Barbosa, et al.
Pageof 83